Pfizer Inc (PFE)
NYSE · Healthcare · Drug Manufacturers - General
Pfizer Inc is a Healthcare company with a market capitalization of $138.44B, a trailing P/E ratio of 18.5, and a dividend yield of 7.27%.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | May 5, 2026 | $0.47 | $0.52 | -9.6% |
| Q4 2025 | February 3, 2026 | $0.66 | $0.57 | +15.8% |
| Q3 2025 | November 4, 2025 | $0.87 | $0.63 | +38.1% |
| Q2 2025 | August 5, 2025 | $0.78 | $0.57 | +36.8% |
| Q1 2025 | April 29, 2025 | $0.92 | $0.67 | +37.3% |
| Q4 2024 | February 4, 2025 | $0.63 | $0.46 | +37.0% |
Other Drug Manufacturers - General Stocks
Frequently Asked Questions
What is Pfizer Inc's market cap?
As of June 29, 2026, Pfizer Inc (PFE) has a market capitalization of $138.44B.
What is Pfizer Inc's P/E ratio?
Pfizer Inc trades at a trailing price-to-earnings (P/E) ratio of 18.5. Its forward P/E is 8.2.
Does Pfizer Inc pay a dividend?
Yes — Pfizer Inc pays a dividend yielding 7.27%, an annual payout of $1.72 per share.
What sector is PFE in?
Pfizer Inc is in the Healthcare sector, specifically the Drug Manufacturers - General industry.
What was Pfizer Inc's revenue?
In its latest reported fiscal year (ending December 31, 2025), Pfizer Inc reported revenue of $62.58B and net income of $7.77B.
Ask your own questions about PFE
Try mrmarket.ai freeData as of June 29, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.